Skip to content

    NOCIL Limited

    NOCILMixed
    Chemicals·3 Nov 2025
    Management Summary

    NOCIL reported a challenging quarter, navigating significant headwinds from import dumping and US tariffs. While the company achieved a 4% sequential volume growth, this was overshadowed by severe pricing pressure, leading to a decline in revenue and profitability. Management is focused on cost-saving initiatives, pursuing anti-dumping measures to level the playing field, and progressing on its Dahej capex, which remains on track for H1 CY26 commissioning. The outlook remains cautious, with exports expected to be choppy and the domestic market's recovery contingent on the outcome of regulatory actions.

    Highlights

    8
    • Net Revenue from operations for Q2 FY26 stood at ₹321 crores, a sequential decline from ₹336 crores in Q1 FY26.

    • Sales volumes grew 4% quarter-on-quarter, though this was offset by softer price realizations.

    • Operating EBITDA for Q2 FY26 was ₹22 crores with an EBITDA margin of 7%, down from ₹31 crores in Q1 FY26.

    • Profit After Tax (PAT) for Q2 FY26 was ₹12 crores, compared to ₹17 crores in Q1 FY26.

    • Capacity utilization is currently around 65%, impacting operating leverage amidst intense competition.

    • The company has filed anti-dumping petitions for key products and expects findings in the next 2-3 months.

    • Export volumes declined due to the US tariff situation, while domestic volumes saw sequential growth.

    • The Dahej expansion project is 75-80% complete, with trial production expected in H1 CY26.

    Concerns

    2
    • Intense pricing pressure from imports (dumping)

    • US Tariffs impacting export volumes

    What Changed2

    vs Q3 FY26

    Guidance items7 → 5 (-2)Q&A highlights7 → 3 (-4)

    Key financials

    Single quarter

    06 metrics
    1. 01Net Revenue₹321 Cr-4.5%QoQ
    2. 02Operating EBITDA₹22 Cr-29.0%QoQ
    3. 03EBITDA Margin7%
    4. 04Operating PBT₹19 Cr-17.4%QoQ
    5. 05Profit After Tax₹12 Cr-29.4%QoQ

    Guidance & targets

    5
    CategoryTargetPriority
    Capex
    Dahej TDQ Capacity Commissioning
    Trial production to commence
    High
    Other
    Anti-dumping petition findings
    Findings to be released
    Medium
    Volume
    Full Year Volume Growth
    Positive growth for the full year
    Low
    Profitability
    Operational Efficiency Measures Impact
    Measures to start coming on stream
    Medium
    Revenue
    New Product Commercial Launch
    Active commercial sales to start
    Medium

    Risks & concerns

    6
    RiskSeverity

    Intense pricing pressure from imports (dumping)

    This is the primary driver of lower price realizations and margin compression. The company is actively pursuing anti-dumping duties as a remedy.Management acknowledged

    high

    US Tariffs impacting export volumes

    Tariffs have caused a decline in export volumes and created a ripple effect in global trade flows. The outlook for exports is 'choppy' in the near term.Management acknowledged

    high

    Low capacity utilization (~65%)

    Operating at 65% utilization limits the company's ability to achieve operating leverage, making it difficult to absorb fixed costs and improve margins.Management acknowledged

    medium

    Competition from Korean players

    Korean competitors are pricing aggressively, even below Chinese players, and benefit from an FTA, adding another layer of competitive pressure.Analyst acknowledged

    medium

    Areas of Evasion(2)

    • Quantum of potential anti-dumping duty
    • Potential delays in duty notification by the Finance Ministry

    Q&A highlights

    3

    “So I think, yes, I did -- I stuck my neck out a few quarters ago and said I think it's bottomed out and then I was wrong. So I'm going to be cautious again because -- okay, again, I feel it's kind of bottoming out because I'm looking at upstream raw material trends and assume that further deflation should not happen. But yes, I'm kind of, let's say, cautious optimism that it's kind of bottoming out, let's say that.”

    Reveals management's uncertainty and caution on the pricing environment after a previous incorrect call, indicating that margin pressure may persist.

    asked by Aditya Khetan

    2 min read5 chapters

    Detailed Narrative

    01

    Q2 Financials: Volumes Grow but Pricing Pressure Hits Margins

    NOCIL's Q2 FY26 performance highlights a challenging market dynamic. The company achieved a 4% sequential growth in sales volumes, indicating resilient underlying demand. However, this was completely offset by intense pricing pressure, primarily from imports. Net revenue fell to ₹321 crores from ₹336 crores in Q1. Consequently, profitability took a significant hit, with Operating EBITDA declining to ₹22 crores at a 7% margin, compared to ₹31 crores in the previous quarter. Profit After Tax also fell sequentially to ₹12 crores from ₹17 crores.

    02

    Domestic Market and Anti-Dumping Measures

    The domestic market, which constitutes two-thirds of the company's volumes, saw sequential growth. However, it remains the primary battleground for import dumping. Management estimates the domestic demand at 80,000-85,000 tons per annum, with NOCIL holding a 38-40% market share. To counter unfair competition, the company has filed anti-dumping petitions on key products (two antioxidants, two sulphonamides). The authorities have initiated an investigation, and management is reasonably confident💬 of a favorable finding within the next 2-3 months, which could be a key catalyst for margin recovery.

    03

    Export Headwinds from US Tariffs

    The export business, representing one-third of volumes, faced a significant setback due to new US tariffs. This led to a decline in export volumes for the quarter and has created broader uncertainty in international markets. Management views this as a 'speed breaker' rather than a full stop and is in discussions with customers. However, they expect the export environment to remain 'choppy' for the next few months. Without the tariff impact🌐, the company's volume index would have been 140-142 instead of the reported 138, indicating a direct impact of 2-4 index points.

    04

    Dahej Expansion Project on Track

    The company's major brownfield expansion for TDQ capacity at Dahej is progressing as planned. Management confirmed that 75-80% of the work is already completed. They are on track to commence trial production during the first half of the calendar year 2026 (H1 CY26). This project is a key part of NOCIL's long-term growth strategy and its timely execution is a positive signal amidst the current operational challenges.

    05

    Margin Pressure, Cost Initiatives, and Capacity Utilization

    The core challenge for NOCIL is profitability, with the company operating at a low 65% capacity utilization. This prevents the absorption of fixed costs and hurts operating leverage. In response, management is implementing various cost optimization and operational efficiency initiatives focused on reducing consumption of steam, electricity, and hydrogen. They expect these measures to start yielding tangible benefits by the fourth quarter of the current financial year. Improved working capital efficiency was a bright spot, driven by better inventory management and lower raw material prices.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.